Wearables, Mobile Health (m-Health), Real-Time Monitoring Share and Cite: Alqarni, A. (2025) Analysis of Decision Support ...

GRAIL, Inc. reports Q3 revenue growth and promising cancer test data, but faces challenges in approval and profitability.

DelveInsight’s comprehensive Phenylketonuria Market Insight, Epidemiology and Market Forecast - 2034 report provides crucial ...

Preclinical data showed imaging agent ACI-19626 can selectively bind to abnormal clumps of the TDP-43 protein, a hallmark of ...

New research from the University of Virginia offers a breakthrough in understanding Alzheimer's, pinpointing the degradation ...

Primary care clinics carry a tough burden. You walk in with concerns about blood pressure, pain or medication questions.

AI-driven oculomics is transforming eye scans into powerful tools for detecting heart, brain, and metabolic health risks ...

Anumana, a leader in AI-powered cardiovascular diagnostics, today announced new groundbreaking clinical data presented at the American Heart Association (AHA) Scientific Sessions 2025. Among the ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.

Q3 2025 Management View CEO Robert Ragusa highlighted "Growth in Galleri volumes and revenue in the third quarter of 2025 were 39% and 29%, respectively, as uptake continues to grow." He noted that ...

Rhythm (Nasdaq: IRTC) today shared new findings supporting the use of its long-term continuous monitoring (LTCM) service.

Epiminder is looking to raise $125 million ahead of an initial public offer as it seeks to commercialise its epilepsy ...